Clinical trial Recruiting at 3 sites Observational Ages 18 to 80

Comparing quality of life in lymphedema patients after surgery versus non-surgical management

Official title: A Prospective Study Comparing Quality of Life in Patients With Lymphedema Who Undergo Surgical Treatment Versus Non-Surgical Management

Run by Memorial Sloan Kettering Cancer Center · NCT03248310 · Data updated 2026-11-12

This study looks at whether surgery or non-surgical treatment helps people with lymphedema feel better in the long run.

More Lymphedema trials

Quick facts

Study typeObservational
Ages18 Years to 80 Years
SexAll
Enrollment600 (estimated)
SponsorMemorial Sloan Kettering Cancer Center
Academic / other
Locations3 sites (Harrison, New York and 2 other locations)
StatusRecruiting
StartedAugust 9, 2017
Main results expectedAugust 2027
Study endsAugust 2027
Registry record updatedSeptember 24, 2026
Trial IDNCT03248310 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18-80 with primary or secondary lymphedema of the upper or lower extremity at ISL stages 1, 2, or 3.

Probably not a fit

Patients with clotting disorders, venous insufficiency, or end-stage lymphedema may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to evaluate the long-term quality of life outcomes for patients with lymphedema who undergo surgical treatment, specifically vascularized lymph node transfer, compared to those who opt for non-surgical management. Participants will be assessed for their quality of life over time, providing insights into the effectiveness of surgical intervention versus conservative treatment. The study includes patients aged 18-80 with varying stages of lymphedema and will exclude those with certain medical conditions or who cannot complete questionnaires.

Why it matters

Potential benefit: If successful, this study could provide valuable information on the benefits of surgical treatment for lymphedema, potentially improving patient care and decision-making.

How similar studies have gone: While this study focuses on a specific surgical approach, similar studies have shown promising results in improving quality of life for lymphedema patients through surgical interventions.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients aged 18-80 years
* Primary and secondary lymphedema of the upper or lower extremity
* International Society of Lymphology (ISL) Stage 1, 2, or 3 lymphedema
* Proficiency in English language

Exclusion Criteria:

* Patients with clotting disorders, venous insufficiency, end-stage lymphedema unless they are on the non-surgical arm.
* Additionally, if the patient refuses to complete questionnaires, the patient will be excluded from the study and replaced at the discretion of the principal or co-principal investigator.

Where it's running

  • Memorial Sloan Kettering Westchester (Limited Protocol Activities)
    Harrison, New York, United States
    Recruiting
  • Memorial Sloan Kettering Cancer Center
    New York, New York, United States
    Recruiting
  • Memorial Sloan Kettering Nassau (Limited Protocol Activites)
    Rockville Centre, New York, United States
    Recruiting

Study contacts

  • Principal investigator: Babak Mahrara, MD — Memorial Sloan Kettering Cancer Center
  • Study coordinator: Babak Mahrara, MD
  • Email: mehrarab@MSKCC.ORG
  • Phone: 646-608-8085

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.